共 19 条
[1]
Jhonson N., Schmid S., Franeschi S., Macdonald D.G., Ferlay J., Bouquot J.E., Et al., Squamous Cell Carcinoma, World Health Organisation Classification of Tumors Pathology & Genetics of Head & Neck Tumors IARC, pp. 168-175, (2005)
[2]
Haraf D.J., Nodzenski E., Brachman D., Mick R., Montag A., Graves D., Vokes E.E., Weichselbaum R.R., Human pappiloma virus and p53 in head and neck cancer: clinical correlates and survival, Clin Cancer Res, 2, 4, pp. 755-762, (1996)
[3]
Girod S.C., Pfeiffer P., Ries J., Pape H.D., Proliferative activity and loss of function of tumor suppressor genes as ‘biomarkers’ in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma, Br J Oral Maxillofac Surg, 36, 4, pp. 252-260, (1998)
[4]
Nylander K., Dabelsteen E., Hall P.A., The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck, J Oral Pathol Med, 29, 9, pp. 413-425, (2000)
[5]
Perez-Ordonez B., Beauchemin M., Jordon R.C., Molecular Biology of Squamous cell Carcinoma of the Head and Neck, J Clin Pathol, 59, 5, pp. 445-453, (2006)
[6]
Gasco M., Crook T., The p53 network in head and neck cancer, Oral Oncol, 39, 3, pp. 222-231, (2003)
[7]
Guimaraes D.P., Hainaut P., TP53: a key gene in human cancer, Biochimie, 84, 1, pp. 83-93, (2002)
[8]
de Oliveira L.R., Ribeiro-Silva A., Zucoloto S., Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma, J Oral Pathol Med, 36, 4, pp. 191-197, (2007)
[9]
Agarwal S., Mathur M., Srivastava A., Ralhan R., MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications, Oral oncol, 35, 2, pp. 209-216, (1999)
[10]
Shiraki M., Odajima T., Ikeda T., Sasaki A., Satoh M., Yamaguchi A., Noguchi M., Nagai I., Hiratsuka H., Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer, Mod Pathol, 18, 11, pp. 1482-1489, (2005)